Search

Medtronic PLC

Closed

SectorHealthcare

92.23 -1.99

Overview

Share price change

24h

Current

Min

92.08

Max

94.71

Key metrics

By Trading Economics

Income

130M

1.3B

Sales

789M

9.8B

P/E

Sector Avg

24.421

57.371

EPS

1.55

Dividend yield

3.11

Profit margin

12.981

Employees

95,000

EBITDA

147M

2.6B

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+1.49% upside

Dividends

By Acuity

Dividend yield

Sector Avg

3.11%

2.23%

Next Earnings

1 wrz 2026

Next Dividend date

16 paź 2026

Next Ex Dividend date

25 wrz 2026

Market Stats

By TradingEconomics

Market Cap

21B

116B

Previous open

94.22

Previous close

92.23

News Sentiment

By Acuity

17%

83%

41 / 340 Ranking in Healthcare

Medtronic PLC Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

19 sie 2026, 23:02 UTC

Medtronic PLC shares are lower in after-market trading, showing unusual weakness despite being above its 20-day moving average and near the upper end of its one-month range.

18 sie 2026, 23:01 UTC

Medtronic PLC shares are slightly higher in after-market hours. The stock remains above its 20-day moving average amid broader market concerns over rising Treasury yields.

17 sie 2026, 20:07 UTC

Social Media

Medtronic PLC shares are lower amid discussions of a potential AVR acquisition. Broader economic concerns include a significant drop in U.S. retail sales.

14 sie 2026, 21:51 UTC

Medtronic PLC shares are lower in after-market hours, with no specific news cited. Broader market declines follow a report of falling U.S. retail sales.

13 sie 2026, 23:01 UTC

Medtronic PLC shares are lower in after-market hours, continuing a decline from earlier losses amid mixed signals on labor market strength and inflation.

12 sie 2026, 23:01 UTC

Medtronic PLC shares are lower in after-market trading, reflecting a retracement from an earlier peak while remaining above the 20-day moving average.

11 sie 2026, 23:01 UTC

Shares of Medtronic PLC were lower during after-market hours, despite a brief uptick earlier in the session. No specific news was identified.

10 sie 2026, 23:21 UTC

Medtronic PLC shares are higher in after-market trading, continuing an upward trend since Monday's close and remaining above the 20-day moving average.

8 sie 2026, 00:02 UTC

Medtronic PLC shares are lower in after-market hours amid a volatile session. A weak jobs report has influenced broader market expectations for interest rate hikes.

7 sie 2026, 23:26 UTC

Medtronic PLC shares are higher in after-market hours, supported by overall market strength and strong performances from major tech stocks.

6 sie 2026, 20:06 UTC

News

Medtronic PLC announced expanded CE Mark approval for its Sphere-9 Catheter, yet shares are trading lower since Wednesday's close after an earlier uptick.

5 sie 2026, 19:52 UTC

News

Medtronic PLC shares are lower today amid increased put options volume, reflecting bearish sentiment ahead of the upcoming earnings report on September 1st.

4 sie 2026, 20:06 UTC

News

Medtronic PLC shares are lower after a jury ruled the company owes $88 million for damages related to Covidien's hernia mesh products.

3 sie 2026, 23:02 UTC

Medtronic PLC shares are lower in after-market hours, reflecting selling pressure despite trading above its 20-day moving average. No specific news was identified.

31 lip 2026, 23:46 UTC

Medtronic PLC shares are trading higher in after-market hours, following unusual trading activity and amid rising U.S. Treasury yields and crude oil prices.

30 lip 2026, 23:31 UTC

Medtronic PLC shares are modestly higher in after-market trading, remaining near the upper end of their one-month range. No specific news was identified.

29 lip 2026, 21:51 UTC

Medtronic PLC shares are lower in after-market hours, reflecting broader market declines amid renewed inflation and interest rate concerns linked to rising crude oil prices.

28 lip 2026, 23:26 UTC

Shares of Medtronic PLC are trading higher in after-market hours, maintaining above the 20-day moving average amid a trend of five consecutive daily gains.

27 lip 2026, 23:46 UTC

Medtronic PLC shares are trading higher in after-market hours, continuing an upward trend and supported by positive sentiment in European markets.

24 lip 2026, 23:26 UTC

Medtronic PLC's after-market trading remains roughly flat, showing routine performance within a narrow range since Friday's close.

23 lip 2026, 23:02 UTC

Medtronic PLC shares are trading higher in after-market hours, reaching near the top of their one-month trading range amid broader market stability.

22 lip 2026, 19:36 UTC

News

Medtronic PLC shares are lower as competition increases from Johnson & Johnson's newly authorized Ottava Surgical Robot for U.S. robotic soft-tissue surgery.

21 lip 2026, 20:07 UTC

News

Medtronic PLC shares are lower today, impacted by declines in the Health Care Equipment sector. The company recently launched its AI-native surgical platform, Touch Surgery™ Aide.

20 lip 2026, 22:31 UTC

Medtronic PLC shares are higher in after-market hours, reflecting positive movement in the Health Care Equipment sub-sector. The stock remains above its 20-day moving average.

Peer Comparison

Price change

Medtronic PLC Forecast

Price Target

By TipRanks

1.49% upside

12 Months Forecast

Average 95.53 USD  1.49%

High 118 USD

Low 80 USD

Based on 19 Wall Street analysts offering 12 month price targets forMedtronic PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

19 ratings

13

Buy

6

Hold

0

Sell

Sentiment

By Acuity

41 / 340 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.
help-icon Live chat